Course Directors:
Maria Oliva-Hemker MD 
Director, Division of Pediatric Gastroenterology, Hepatology and Nutrition
Stermer Family Professor of Pediatric Inflammatory Bowel Disease
Vice Dean for Faculty
Johns Hopkins University School of Medicine
Baltimore, MD

Toba Weinstein, MD
Professor of Pediatrics
Fellowship Training Program Director
Division of Pediatric Gastroenterology
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Cohen Children's Medical Center
Northwell Health

Postgraduate Course

Thursday, October 13, 2022
8:00 AM - 4:00 PM

Postgraduate Course Syllabus
(Adobe PDF File)
8:00 AM - 9:00 AM Module 1: Endoscopy
Moderators: Javier Monagas, MD, Baylor College of Medicine and Maria Oliva-Hemker, MD, Hopkins University School of Medicine

8:00 AM Foreign Body Ingestions
Petar Mamula, MD, Children's Hospital of Philadelphia
                     Learning objectives:
  • Describe different types of foreign body ingestion in the pediatric population
  • Discuss ingestion complications with an emphasis on magnets and lithium battery ingestions
  • Review algorithms for treatment of various types of foreign body ingestions
8:20 AM Conquering GI strictures
Sabina Ahmed Mir, MD, University of North Carolina Chapel Hill
Learning objectives:
  • Discuss the etiology of GI strictures in the pediatric population
  • Review the appropriate diagnostic evaluation
  • Describe the endoscopic approach to treatment
8:40 AM Polyps: To cut…Or to cut and run?
Brad Barth, MD, MPH, UT Southwestern and Children’s Medical Center Dallas
Learning objectives:
  • Review the characteristics of high risk polyps
  • Describe the most up to date interventions including cold snare polypectomy
  • Discuss reasons to refer to expert centers for assistance
9:00 AM - 10:20 AM Module 2: Liver/Pancreas
Moderators: Ann Ming Yeh, MD, Stanford University and Toba Weinstein, MD, Children's Medical Center, Northwell Health

9:00 AM Evaluation of the jaundiced infant
Saul Karpen, MD, PhD, Emory University
Learning objectives:
  • Describe the appropriate  evaluation of an infant with a direct bilirubin > 1.0 mg/dl at 48 hours of life
  • Summarize the key components of the most recent joint NASPGHAN-ESPGHAN Guidelines on the Evaluation of the Cholestatic Infant, with incorporation of information and tools available since publication in 2017
  • Develop a means to decide upon utilization of genetic testing and/or liver biopsy in your evaluation of the cholestatic infant
  • Define the language common to genetic testing reports—benign, pathogenic, VOUS, etc…
  • Describe the current status of the field regarding recently-approved anticholestatic therapies for Alagille Syndrome and PFICs
9:20 AM Managing the patient with acute pancreatitis: Beyond the basics
Aliye Uc, MD, University of Iowa Health Care
Learning objectives:
  • Identify risk factors and predictors associated with pancreatitis disease severity
  • Plan management of patients based on pancreatitis disease severity
  • Assess potential pancreatitis complications and plan therapy
9:40 AM Imaging of the pancreas: Practical tips from you friendly radiologist
Andrew T. Trout, MD, Cincinnati Children's Hospital Medical Center
                     Learning objectives:
  • Optimize selection of imaging for acute and chronic pancreatitis
  • Define the relative benefits of US, CT and MRI for imaging of pancreatic disease
  • Recognize the role of intravenous contrast material in imaging of pancreatic disease
10:00 AM Acute liver failure
James Squires, MD, MS, UPMC Children’s Hospital of Pittsburgh
                     Learning objectives:
  • Recognize the clinical presentation and progression of pediatric acute liver failure
  • Discuss an age-based diagnostic approach and clinical management of PALF
  • Describe acute hepatitis outbreak and the future of PALF investigation
10:20 AM - 10:40 AM Break
10:40 AM - 12:00 PM Module 3: Inflammatory Diseases
Moderators: Riha Bhatt, MD, Vanderbilt Children's Hospital and Maria Oliva-Hemker, MD, Hopkins University School of Medicine

10:40 AM Oral small molecules in IBD 
Anne M. Griffiths, MD, FRCPC, Hospital for Sick Children
                     Learning objectives 
  • Appreciate the pathways targeted by new oral small molecules in use or on the horizon for pediatric IBD
  • Describe the efficacy and safety of Janus kinase (JAK) inhibitors and sphingosine-1-phosphate (S1P) receptor modulators in IBD
  • Recognize how to recommend positioning of small molecules relative to biologics in Crohn’s disease and ulcerative colitis
11:00 AM Preventative Medicine  in the IBD patient
Sabina Ali, MD, UCSF Benioff Children's Hospital
                     Learning objectives:
  • Review the literature and guidance on preventive health measures in inflammatory bowel disease (IBD)
  • Review recommended immunizations for patients with IBD
  • Identify how to integrate preventive screenings into practice to improve health outcomes in all patients with IBD
11:20 AM Managing the Child with VEO-IBD
Judith Kelsen, MD, Children's Hospital of Philadelphia
Learning objectives:
  • Review the underlying disease drivers in VEO-IBD
  • Describe the predominant phenotypes in children with VEO-IBD
  • Review the comprehensive evaluation for children with VEO-IBD, including immune and genetic analyses
  • Discuss the range of therapeutic options for children with VEO-IBD
11:40 AM Treat to Target in IBD
Jeremy Adler, MD, MSc, University of Michigan
Learning objectives:
  • Review evidence for “treat to target” as a strategy for IBD
  • Review evidence for specific treatment targets
  • Review pediatric-specific evidence
  • Identify a practical approach to treating to target for pediatric IBD
12:00 PM - 1:40 PM Lunch on your own
1:40 PM - 3:00 PM Module 4: Potpourri
Moderators: Alexander Koral, MD, Yale School of Medicine and Toba Weinstein, MD, Children's Medical Center, Northwell Health

1:40 PM COVID effects on the GI/hepatobiliary tract
Kara Gross Margolis, MD, New York University
Learning objectives:
  • Describe the pathogenesis of COVID in the GI tract
  • Identify the risk factors for COVID associated with specific GI diseases
  • Recognize existing guidelines for those with COVID and underlying GI conditions
2:00 PM Calling a GI Consult: Growth & Nutrition Issues in NICU Infants
Timothy A. Sentongo, MD, University of Chicago
Learning objectives:
  • Identify how to reliably predict mortality and prognosis in newborn and preterm infants
  • Review manifestations, work up and differential diagnosis for GI disorders in the NICU patient
  • Discuss management options for obvious and obscure GI disorders in newborn and preterm infants
2:20 PM Updates on the diagnosis and treatment of gluten related disorders
Maureen Leonard, MD, Massachusetts General Hospital
Learning objectives:
  • Review updated diagnostic criteria for children with celiac disease
  • Describe recommendations for management of children with gluten related disorders
  • Recognize alternative treatment strategies in clinical development
2:40 PM What’s new for the use of PPIs 
Benjamin D. Gold, MD, FAAP, NASPGHAN-F, Gi Care for Kids, LLC
Learning objectives:
  • Provide overview of the history behind development of proton pump inhibitors (PPIs) with a recognition of why improvements in acid suppression were needed. Point out when concerns about PPIs were raised, misuse and overuse
  • Review gastroesophageal reflux (GER) in comparison to gastroesophageal reflux disease (GERD) in pediatrics. Phenotyping GERD; key for optimizing treatment of reflux disease
  • Recognize why PPIs are key in the management of specific aerodigestive diseases
  • Review the diagnosis of eosinophilic esophagitis and role of PPIs in treatment, moving away from PPI-REE and why EoE is important to understand in managing aerodigestive disease
  • Review evidence-based guidelines for treatment of Helicobacter pylori (H. pylori) infection in children and importance of PPIs in treatment
  • Describe the rationale for use of PPIs in NSAID associated gastro-duodenal inflammation and the role of acid suppression in gastrointestinal bleeding
  • Evaluate future directions: promotility + acid suppression
3:00 PM - 4:00 PM Module 5: Disorders of the Brain-Gut Interaction/Motility
Moderators: Vrinda Bhardwaj, MD, Children's Hospital Los Angeles and Maria Oliva-Hemker, MD, Hopkins University School of Medicine

3:00 PM Esophageal motility disorders
Rachel Rosen, MD, Boston Children's Hospital
Learning objectives:
  • Recognize the relationship between symptoms, dysmotility and functional disorders
  • Describe new diagnostic tools to diagnose esophageal motor disorders
  • Review the novel therapies available to treat esophageal motility disorders
3:20 PM Functional Nausea
Katja Kovacic, MD, Medical College of Wisconsin
Learning objectives: The learner will understand:
  • Describe plausible mechanisms underlying chronic 'functional' nausea
  • Identify diagnostic approaches
  • Describe available therapeutic options
3:40 PM Constipation: The importance of having an evacuation plan
Carlo Di Lorenzo, MD, Nationwide Children's Hospital
Learning objectives:
  • Discuss the testing needed in the evaluation of a child with severe constipation
  • Illustrate when and how to use novel medications
  • Explain the role of surgical interventions in the management of the child with intractable constipation
** Please note sessions with this mark will not be recorded for viewing online.
The recordings of sessions will be unedited. Virtual attendees will not be able to interact with the sessions other than viewing. All registrants, if they attend in person or virtually, will have access to the recorded sessions. More details will be posted shortly.